Top Markets
Coin of the day
MetaStat Inc MetaStat Inc

MetaStat Inc

MTST
Rank in Stocks #42020
MetaStat, Inc., a precision medicine company, focuses on discovering and... MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company’s therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.
Share Price
$0.001
Last synced: 2026-08-11
Market Cap
$5.88K
Change (1 day)
0.00%
Change (1 year)
400.00%
Country
US
Trade MetaStat Inc (MTST)

Category

Stock price history for MetaStat Inc (MTST)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $8.64K on 2009-01-01
Stock price history of MetaStat Inc from 2009 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 463.64%
2024 0.00%
2023 0.00%
2022 -94.49%
2021 -97.16%
2020 -66.02%
2019 -80.17%
2018 -86.53%
2017 -59.23%
2016 -66.02%
2015 -30.12%
2014 -67.24%
2013 -59.82%
2012 145.63%
2011 -91.79%
2010 111.42%
2009 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$57.04 49.56%
CN
$108.57 62.31%
CH
$460.07 28.69%
IE
$287.89 109.53%
US
$8.66 81.64%
TH